A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Taiho Oncology, Inc.
Jazz Pharmaceuticals
Bayer
Seagen Inc.
AstraZeneca
Prelude Therapeutics
Daiichi Sankyo
Shanghai Henlius Biotech
Shenyang Sunshine Pharmaceutical Co., LTD.
BeOne Medicines
Tempus AI
Sichuan Baili Pharmaceutical Co., Ltd.
Jazz Pharmaceuticals
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
PhytoHealth Corporation
Janssen Research & Development, LLC
Elevation Oncology
Hansoh BioMedical R&D Company
Highlight Therapeutics
Janssen Pharmaceutical K.K.
Adaptimmune
Apexigen America, Inc.
Catalysis SL
pharmaand GmbH
Merck Sharp & Dohme LLC
Boston Scientific Corporation
Seagen Inc.
Takeda
MultiVir, Inc.
Eli Lilly and Company
Betta Pharmaceuticals Co., Ltd.
Aduro Biotech, Inc.
Merck KGaA, Darmstadt, Germany
Merrimack Pharmaceuticals
Merck Sharp & Dohme LLC
Cornerstone Pharmaceuticals
Shenzhen Hornetcorn Bio-technology Company, LTD
Eli Lilly and Company
Cancer Advances Inc.
Pinnacle Biologics Inc.
Delcath Systems Inc.
Bristol-Myers Squibb
Jiangsu Simcere Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
GlaxoSmithKline
Daiichi Sankyo
PharmaEngine
GenVec